Lantern Pharma Inc.
LTRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,781 | -$15,962 | -$14,260 | -$12,363 |
| Dep. & Amort. | $190 | $15 | $10 | $7 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,068 | $1,188 | $962 |
| Change in WC | $2,228 | $538 | -$612 | $600 |
| Other Non-Cash | $549 | -$5 | $906 | $203 |
| Operating Cash Flow | -$17,813 | -$14,347 | -$12,767 | -$10,592 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13 | -$19 | -$28 | -$15 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$17,276 | -$8,196 | -$3,913 | -$19,579 |
| Inv. Sales/Matur. | $20,658 | $7,285 | $4,120 | $64 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $3,369 | -$930 | $179 | -$19,531 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $67 | $0 | $0 | $69,000 |
| Stock Repurch. | $0 | -$500 | -$2,482 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $300 | -$5,584 |
| Financing Cash Flow | $67 | -$500 | -$2,182 | $63,416 |
| Forex Effect | -$50 | -$28 | -$11 | $1 |
| Net Chg. in Cash | -$14,427 | -$15,805 | -$14,781 | $33,295 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21,938 | $37,743 | $52,524 | $19,229 |
| End Cash | $7,511 | $21,938 | $37,743 | $52,524 |
| Free Cash Flow | -$17,826 | -$14,365 | -$12,795 | -$10,607 |